Previous 10 | Next 10 |
AndrewJohnson/E+ via Getty Images After over a fourfold rise value yesterday, Orphazyme ([[ORPH]] -44.3%) has lost more than a third so far in morning hours. Issuing a clarification, the company said that it was not aware of any reason that caused such extreme volatility in price and vol...
Orphazyme (ORPH) -49% Orphazyme stock losing half its value premarket, after rocketing fourfold the day beforeCVR Energy (CVI) -18%.Curis (CRIS) -13% on updated data for CA-4948 in blood cancers.Galecto (GLTO) -16%.Aptose Biosciences (APTO) -15% presents highlights from EH...
monsitj/iStock via Getty Images Gamestop (GME) continued to grab headlines during Thursday's session, as the stock dropped nearly 30% in the wake of its quarterly earnings. Meanwhile, RH (RH) saw an opposite reaction to its results. Shares of the home products retailer climbed more than 15% o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Orphazyme (NASDAQ: ORPH ) experienced wild gains. Orphazyme stock closed higher by more than 300%, but at one point, shares were up 1,000%. That is simply spectacular. Source: S...
Canberk Sezer/iStock via Getty Images Orphazyme ([[ORPH]] +984.1%) and CytRx ([[CYTR]] +73.5%) have reached their historical high as the companies await the FDA decision on Arimoclomol in the treatment of Niemann-Pick Disease Type C ((NPC)), a rare genetic disease. The experimental treatment ...
4 Hot Penny Stocks to Watch in 2021 Penny stocks are some of the most popular securities among traders right now. And, there’s a good reason for that. For one, the low price of penny stocks means that they have the potential to make major intraday jumps or falls in value. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, Orphazyme (NASDAQ: ORPH ) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing. Source: Shutterstock This is a stock that closed yesterday trading at ...
Gainers: Orphazyme (ORPH) +193%.Trxade Group (MEDS) +142%.Medley Management (MDLY) +61%.Sphere 3D (ANY) +54%.Yiren Digital (YRD) +25%.Orbsat Corp (OSAT) +22%.Alset EHome International (AEI) +22%.Xinyuan Real Estate (XIN) +21%.Support.com (SPRT) +20%.RH (RH) +14%.Losers: Aethlon...
Gainers: BriaCell Therapeutics BCTX +151%, Constellation Pharmaceuticals CNST +67%, Soleno Therapeutics SLNO +46%, Stealth BioTherapeutics (MITO) +24%, Aerpio Pharmaceuticals (ARPO) +9%.Losers: iRhythm Technologies IRTC -18%, Progenity (P...
Gainers: InnSuites Hospitality Trust (IHT) +95%.Regional Health Properties (RHE) +30%.Cooper-Standard (CPS) +25%.MoneyGram International (MGI) +23%.Epizyme (EPZM) +21%.The L.S. Starrett (SCX) +21%.Clene (CLNN) +20%.Yield10 Bioscience (YTEN) +20%.Phio Pharmaceuticals (PHIO) +19%.Core...
News, Short Squeeze, Breakout and More Instantly...
Orphazyme A/S Company Name:
ORPH Stock Symbol:
NASDAQ Market:
(NewsDirect) hVIVO PLC (AIM:HVO) chief executive Yamin 'Mo' Khan discusses the company's record-breaking financial results in 2023 in an interview with Proactive's Stephen Gunnion. hVIVO announced a 16% year-on-year growth in revenue, reaching £56 million, with an EBITDA margin i...
(NewsDirect) hVIVO chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions whil...
(NewsDirect) hVIVO PLC (AIM:HVO) Chief Scientific Officer Andrew Catchpole speaks to Steve Darling from Proactive after the specialist contract research organisation announced it has secured a £6.3 million contract with a biotechnology client for the testing of their antiviral candid...